Open access · US-GOV via ClinicalTrials.gov Clinical trial

Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

Authors not listed

Institut de Cancérologie de Lorraine · 2015

Altered intercellular communication Human Randomized controlled trial

Abstract

The primary objective of this study was to validate Total Psoas Area (TPA) measurement as an independent prognostic factor of overall survival in patients with pancreatic adenocarcinoma. Secondary objective was to describe the evolution of the TPA during the follow-up.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-12 MST

Cite this

APA

Anonymous. (2015). Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma. <em>Institut de Cancérologie de Lorraine</em>. https://clinicaltrials.gov/study/NCT02977702

Vancouver

Anonymous. Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma. Institut de Cancérologie de Lorraine. 2015.

BibTeX

@misc{anon2015Sarcop, title = {Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma}, author = {Anonymous}, journal = {Institut de Cancérologie de Lorraine}, year = {2015}, }